Skip to content
World clockEU--:--UK--:--USA--:--CN--:--PLDEFRIT中文EN

portal about AI and technologyevents · analysis · interviews · technical background

Search
LIVE
›

Fibromyalgia study of 2.5 million people identifies 26 genetic risk loci

A 28 July 2026 Nature Medicine meta-analysis of 2,563,755 people found 26 genetic risk loci for fibromyalgia, a chronic pain syndrome. Authors say it is mainly a central nervous system disorder, not primarily autoimmune, with a possible peripheral immune component.

ScienceExplainerSofia MarchettiPublished: 10 November 20263 min readSources 24
Fibromyalgia study of 2.5 million people identifies 26 genetic risk loci

Fibromyalgia is a chronic pain syndrome marked by widespread pain and tenderness, fatigue, and problems with sleep, memory and mood. It is diagnosed roughly three times more often in women than in men, and affects about 2% of the global population, according to the study announcement. The meta-analysis compared 54,629 cases with 2,509,126 controls and found 26 genetic risk loci, regions of the genome associated with the condition, with the strongest association in HTT, the gene whose other mutations cause Huntington's disease.

What the meta-analysis covered

The study pooled 11 cohorts from the US, UK, Finland, Estonia, Denmark and Iceland, and involved 53 researchers across seven countries, according to the study announcement. It drew on 2,563,755 individuals in total, the paper reports. Michael Wainberg of the Lunenfeld-Tanenbaum Research Institute co-led the work with Nasa Sinnott-Armstrong of Fred Hutch Cancer Center and the University of Washington, and Hanna Ollila of the University of Helsinki and Massachusetts General Hospital. Wainberg said fibromyalgia was known to run in families, yet nobody had found strong genetic risk factors for it.

The paper is titled "The genetic architecture of fibromyalgia across 2.5 million individuals". The researchers have founded the Chronic Pain Genomics Consortium to study other chronic pain syndromes, starting with pelvic pain, the study announcement said.

The Huntington's signal

The strongest association was a coding variant in HTT, the gene whose other mutations cause Huntington's disease. Wainberg said the variant deletes a single amino acid from the Huntingtin protein. It is a different type of variant in a different part of the protein from the one that causes Huntington's, so it is not a Huntington's risk factor, he said. The authors wrote that the variant carries roughly a 9% increased risk of fibromyalgia and is distinct from the rare repeat expansion that causes Huntington's disease. Gene prioritisation implicated GPR52, a regulator of HTT, and the authors also observed an association near GPR52, which is already being investigated as a drug target in Huntington's disease.

Frances Williams, a rheumatologist at King's College London and a co-author, said one implicated pathway is already the focus of drug trials for Huntington's disease, raising the possibility that existing pharmaceutical research could eventually benefit people with fibromyalgia, RTE reported.

Nervous system, not immune system

Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types, the authors report. Gene prioritisation implicated DCC, DRD2/NCAM1, MDGA2 and CELF4, genes with neural roles in pain processing, synaptic transmission and neuronal survival. The team also integrated the 26 loci with a dataset of 20 million cells from various tissues and found genes near the risk variants were more active in nervous system cells than in other cell types, which the study announcement says sets fibromyalgia apart from classical autoimmune conditions.

Overlap with other conditions

Fibromyalgia shared genetic risk with low back pain, post-traumatic stress disorder and irritable bowel syndrome, with correlations above 0.7, the paper reports. The genetic architecture was nearly identical between males and females, despite fibromyalgia being diagnosed roughly three times more often in women than in men. Williams said chronic pain syndromes cluster together in individuals and families and are genetically similar, and that targeting shared mechanisms could potentially benefit a whole cluster of disorders. The authors think shared mechanisms within the nervous system may make people susceptible to several of these conditions at once.

What is still unknown

Genetics is not the main determinant of who develops fibromyalgia, the study found. The authors suspect that even people carrying many risk variants likely need another risk factor, such as a painful arthritic condition, to trigger the syndrome. The findings do not mean fibromyalgia can now be diagnosed with a genetic test, nor do they immediately lead to a new treatment, the researchers said. The study announcement put prevalence at about 2% of the global population; Technology Networks reported a range of 2% to 8%, and RTE reported around 5% in the UK and Ireland.

Sinnott-Armstrong said in the study announcement that further research into triggers of fibromyalgia and corresponding changes to neural tissues will help determine what drives the condition and how to treat it.

Comments 0

Sources

24
  1. 01Largest-Ever Genetic Study of Fibromyalgia Reveals Biological Roots of Chronic PainEN
  2. 02A Meta-Analysis Uncovers Genetic Risk Factors for FibromyalgiaEN
  3. 03Largest-Ever Genetic Study of Fibromyalgia Points to a Neurological OriginEN
  4. 04Largest-ever genetic study of fibromyalgia points to a neurological origin of the disorder and opens the door to new treatmentsEN
  5. 05From Nature.com "The genetic architecture of fibromyalgia across 2.5 million individuals" including the Huntington's connectionEN
  6. 06Fibromyalgia has 'clear biological basis', genetic study findsEN
  7. 07Genetic Study of Fibromyalgia Points to Neurological BasisEN
  8. 08Genetic link found in chronic pain disorderEN
  9. 09West Yorkshire’s £229 Million Bus Decisions Will Outlast Its Operating ContractsEN
  10. 10 NASA just launched a $1 million Moon Base Student Challenge to award cash prizes to students that solve lunar base problems EN
  11. 11BYD reaches 19 million NEV production milestone as Fang Cheng Bao opens Tai 9 reservationsEN
  12. 12SEGA newsletter data breach exposes 2.2 million email addressesEN
  13. 13FBI agent stole $2.5 million in crypto from hackers under investigationEN
  14. 14Deep Read: ME/CFS – die Krankheit, die Millionen Menschen vom Leben ausschließtEN
  15. 15Ukraine dismantles crypto scam network that stole €4.3 millionEN
  16. 16Article: Agentic AI Architecture: Current Challenges and Future OpportunitiesEN
  17. 17Iris Ohyama data cloud breach exposes info of 7.7 million customersEN
  18. 18Elon Musk Threw Away $474 Million (Or More) … But May Benefit From FailingEN
  19. 19Cloudflare Scales D1 Control Plane to Millions of DatabasesEN
  20. 20Hackers pull off $133 million French bank heist via service providerEN
  21. 21CesiumAstro Secures $730 Million in Janus Henderson-Led Series D at a Valuation Above $4.5 Billion; Unveils Synchronicity Satellite Constellation Following FullEN
  22. 22Launch HN: Rivet (YC W23) – Scale and Orchestrate Agents on S3EN
  23. 23China’s CXMT defends bet on risky new DRAM architecture to circumvent US chip curbsEN
  24. 24How AI Is Changing the Pace of Discovery for Millions Living With DementiaEN

All figures and quotations in this text come from the sources listed below.

Content prepared by the editorial team with AI assistance.

Sofia Marchetti

Sofia Marchetti

Science and health

Sofia Marchetti covers science and health for FLASH24, working from primary literature, preprints, and agency data rather than press releases. She checks sample sizes, confidence intervals, and whether a study's numbers match its abstract before filing. She interviews researchers and clinicians directly, tracks conference calendars for embargoed results, and compares new findings with earlier trials on the same question. Outside the newsroom she works on materials physics and stargazes through a home telescope, which keeps her close to how measurement error actually behaves. She does not publish a health claim without a named source and the underlying data.

Newsroom →

Comments

0
  1. No comments yet — be the first.

Write a comment

Comments are public. We do not publish abuse, spam or advertising.